Addition Therapeutics, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-22. The offering totals $28.0M, of which $28.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Peter Bisgaard | Director | South San Francisco, CA |
| Kathleen Collins | Director | South San Francisco, CA |
| Jennifer Lee | Director | South San Francisco, CA |
| Ronald Park | Director | South San Francisco, CA |
| Matthew Patterson | Director | South San Francisco, CA |
| Jayson Punwani | Director | South San Francisco, CA |
| Laetitia Schwab | Director | South San Francisco, CA |
| Lawrence Kong | Executive Officer | South San Francisco, CA |
| Ronald Park | Executive Officer | South San Francisco, CA |